Kristine Marie Ward, MD

Hematology, Medical Oncology
Accepting new patients
Sees patients age 18 and up
Penn Hematology/Oncology Pennsylvania Hospital
View 1 additional location
Headshot of Kristine Marie Ward, MD
Penn Medicine Provider

About me

  • Clinical Assistant Professor of Medicine (Hematology-Oncology)

My education and training

  • Medical School: Thomas Jefferson University
  • Residency: Lankenau Medical Center
  • Residency: Pennsylvania Hospital
  • Fellowship: Drexel University College of Medicine

Spoken languages

English
English

Reviews

Average Rating

363 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
April 2026
i feel dr. ward goes over and beyond your treatment
Anonymous
April 2026
she's very knowledgeable
Anonymous
April 2026
dr. ward is very thorough, knows her patients well, and is very knowledgeable in her area of expertise!
Anonymous
April 2026
solid knowledge of my medical history and other specialists

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
Dr. Ward is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Hugo Lara- Martinez, Kristine Ward Michael Styler, Praneeth Baratam Angiosarcoma of the Face: A Case Study and Literature Review of Local and Metastatic Angiosarcoma , Case Reports in Oncological Medicine , 2021: 2021


S Bukhari Kristine Ward Michael Styler Hepatocellular Carcinoma First Manifestation as Solitary Humeral Bone Metastasis , Case Reports in Oncological Medicine : 2020


Ronak Mistry Kristine Ward Sickle Induced Cholestasis: A Rare but Fatal Complication of Sickle Cell Disease , PA ACP Southeastern Chapter Abstract # 31: 2020


Wilbur Bowne, Michael J Styler Kristine Ward targeting membrane HDM 2 by PNC 27 Induces Necrosis in leukemia Cells but not in normal Hematopoietic Cells , Anticancer Research , 40(9): 2020,4857-4867


Kyung D, Perimbeti S, Adepoju B, Hanson S, McCormack M, Ward K, Jain M, Styler M Relationship between underlying causes of HCC and its complications , J Clin Oncol: 2019


Bemis T, Baratam P, Seiders D, Ward K, Styler M Impact of timing of palliative care team consults in patients with advanced cancer , J Clin Oncol: 2019


Perimbeti S, Shrivastav R, Stanchina M, Pathak P, Rainone M, Jain M, Ward K, Styler M Trends in mortality due to hypercalcemia in breast cancer. , J Clin Oncol: 2019


Perimbeti S, Shrivastav R, Jatwani K, Ward K, Styler M, Jain M, Nandi N Impact of Clostridium difficile infection on gastrointestinal malignancies , J Clin Oncol: 2019


Gleeson EM, Feldman R, Mapow BL, Mackovick LT, Ward KM, Morano WF, Rubin RR, Bowne WB. Appendix-derived Pseudomyxoma Peritonei (PMP): Molecular Profiling Toward Treatment of a Rare Malignancy. , Am J Clin Oncol., 41(8): 2018,777-783


Schmalz L, Trisel Z, Perimbeti S, Lee W, Topolsky D, Crilley P, Ward K, Styler M Malignant pleural effusions: Do race, obesity and comorbidities play a role? , J Clin Oncol: 2018